Literature DB >> 13937554

Prophylactic effect of antivaccinia gamma-globulin against post-vaccinal encephalitis.

W NANNING.   

Abstract

In the Netherlands, the frequency of encephalitis after smallpox vaccination is estimated to be 1 in 4000 primary vaccinations in adults and 1 in 50 000 revaccinations. Since immunity seems to reduce the frequency of this complication, it was thought that it might be possible to prevent post-vaccinal encephalitis by a combination of passive and active immunization, a basic immunity being obtainable without risk by the injection of antivaccinia gamma-globulin (AGG). This theory was tested in Dutch military recruits in a double-blind experiment. At the time of primary vaccination the recruits were given an injection in the other arm, either of 2 ml of 16% AGG (treated group) or of 2 ml of placebo solution (control group).It appeared that administration of AGG had a prophylactic effect, since only 3 cases of post-vaccinal encephalitis occurred among the 53 630 recruits in the treated group, as compared with 13 among the 53 044 recruits in the control group. The difference of 10 is significant. The best estimate of the reduction in the frequency brought about by injection of 2 ml of 16% AGG is 77%; the lower limit of this reduction is 29%.The administration of 2 ml of 16% AGG did not interfere with the development of active immunity.

Entities:  

Keywords:  ENCEPHALITIS, POST-VACCINAL; GAMMA GLOBULIN; SMALLPOX VACCINE; VACCINIA VIRUS

Mesh:

Substances:

Year:  1962        PMID: 13937554      PMCID: PMC2555763     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  1 in total

1.  The effect of antivaccinia gamma globulin on smallpox vaccination in view of a proposed attempt to prevent postvaccinal encephalitis.

Authors:  R GISPEN; H P LANSBERG; W NANNING
Journal:  Antonie Van Leeuwenhoek       Date:  1956       Impact factor: 2.271

  1 in total
  8 in total

Review 1.  Passive immunity in prevention and treatment of infectious diseases.

Authors:  M A Keller; E R Stiehm
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Primary vaccination with an attenuated strain of vaccinia virus.

Authors:  J van der Noordaa; F Dekking; J Posthuma; B J Beunders
Journal:  Arch Gesamte Virusforsch       Date:  1967

3.  [Studies on the effect of Marboran, antivaccine hyperimmune serum and preliminary inoculation with vaccine antigen on intracutaneous vaccination in rabbits].

Authors:  M Y Käckell; K E Schneweis; H Spiess
Journal:  Klin Wochenschr       Date:  1966-10-15

4.  A COMPARATIVE STUDY OF CLINICAL REACTION OBSERVED AFTER APPLICATION OF SEVERAL SMALLPOX VACCINES IN PRIMARY VACCINATION OF YOUNG ADULTS.

Authors:  M F POLAK; B J BEUNDERS; A R VAN DER WERFF; E W SANDERS; J VAN KLAVEREN; L M BRANS
Journal:  Bull World Health Organ       Date:  1963       Impact factor: 9.408

5.  Vaccinia Ig ameliorates eczema vaccinatum in a murine model of atopic dermatitis.

Authors:  Michiko K Oyoshi; Narayanaswamy Ramesh; Raif S Geha
Journal:  J Invest Dermatol       Date:  2011-12-22       Impact factor: 8.551

6.  Developing new smallpox vaccines.

Authors:  S R Rosenthal; M Merchlinsky; C Kleppinger; K L Goldenthal
Journal:  Emerg Infect Dis       Date:  2001 Nov-Dec       Impact factor: 6.883

Review 7.  Challenges and Achievements in Prevention and Treatment of Smallpox.

Authors:  Sharon Melamed; Tomer Israely; Nir Paran
Journal:  Vaccines (Basel)       Date:  2018-01-29

Review 8.  Bioterrorism and children: unique concerns with infection control and vaccination.

Authors:  Kay B Leissner; Robert S Holzman; Mary Ellen McCann
Journal:  Anesthesiol Clin North Am       Date:  2004-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.